Immunohistological evidence indicates that neuropeptide Y (NPY) is present in the cardiac
innervation of numerous species. The present experiments determined if NPY influences in …

The cardiovascular role of the neuropeptide Y Y1 receptors in‐vivo and in‐vitro in ischaemic
heart failure was evaluated by using the novel neuropeptide Y Y1 selective antagonist BIBP …

Neuropeptide Y (NPY) is present in the brain, the adrenal medulla, and peripheral
sympathetic nerves. This peptide is released together with catecholamines during …

Yet another 'orphan'molecule that had to find its place in life after isolation and sequencing,
neuropeptide Y appears to be an important cardiovascular neuroregulator and also links the …

The effects of neuropeptide Y (NPY, 10 μg/kg bolus iv) on renal, mesenteric and hindlimb
blood flow were determined in intact conscious rabbits with chronically implanted Doppler …

Cardiac disease is marked by sympathoexcitation and elevated levels of noradrenaline (NA)
and cotransmitter neuropeptide Y (NPY). Increased NPY levels are associated with a greater …

The haemodynamic effects of intracerebroventricular (icv) administration of neuropeptide Y
(NPY) in urethane-anaesthetized rats were studied. In Sprague-Dawley rats, NPY increased …

The effect of intrathecal administration of neuropeptide Y (NPY), NPY COOH-terminal
fragments as well as an NPY Y, receptor ligand on arterial blood pressure (ABP) of …

Neuropeptide Y (NPY) is closely associated to stress-reactive structures in the central and
peripheral nervous system. In the periphery, the peptide is colocalized with catecholamines …